chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Debilitating migraine and body aches which had lead to inability to drive, function/ work normally. Severe head pain going from seated to standing. Nausea. On going for four days. Symptoms incredibly worse than first and second Covid shots. No history of severe ongoing migraines.
Very sore arm with four in red spot. Temperature reached 102.5 then two Extra Strength TYLENOL every six hours. By the second dose most of symptoms were relieved.
Hives at injection site 8 days after injection followed by 2 days of redness and intense itching.
Muscle weakness; This spontaneous case was reported by a consumer and describes the occurrence of MUSCULAR WEAKNESS (Muscle weakness) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced MUSCULAR WEAKNESS (Muscle weakness). At the time of the report, MUSCULAR WEAKNESS (Muscle weakness) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant medications were not reported. Treatment information was not provided.   This case was linked to MOD-2021-240745 (Patient Link).
Pt had N/V, fever, nasal congestion, sore throat, decreased sleep, facial rash, HA, myalgia. No relieve w/ OTC Benadryl. Exam at ED found neck pain w/ flexion consistent with meningismus and RUA tenderness, (+) Murphy sign. Admitted to hospital, IV fluids and IV antibiotics. Discharged home in improving condition.  03/28/2008 MR received with VAERS report for DOS 3/2-4/2008 with D/C DX:  Acute sinusitis/viral syndrome (respiratory syncytial virus) and myalgias possibly due to immunizations that she received last week.  Gastritis. Pt presented to ER with fever, sore throat, vomiting and facial rash.  Pt with c/o stiff neck and h/a. PE (+) for facial petechiae, neck pain c/w meningismus and RUQ tenderness. Txd with abx and IVF and d/c improved 3/4/08.
Pruritus onset 2/20/23 in evening, then red itchy rash by 8AM 2/21/23 that spread over next 24 hours and was associated with mild cough. Onset of low-grade fever 99-100 on AM 2/22/23, followed by headache midday 2/22/23. Cough and low-grade resolved by end of 2/22/23. Stable pruritus and rash 2/23/23.
Headache, Arthralgia, Fever, Chills, Rigors Narrative:  Other Relevant History:
This medically confirmed, Health Authority report (initial receipt 21-Aug-2013) involves a patient (no patient identifiers reported). On an unreported date, the patient received AFLURIA (batch number: 073492211A, batch number provided not for AFLURIA). On an unreported date, the patient developed paralysis of both legs resulting in inability to walk/abasia. The patient received an nuclear magnetic resonance imaging (MRI) and was treated with steroids. The patient was discharged from hospital on 11-Jan-2013. The patient continued to receive ongoing therapy. Outcome for the events was not yet recovered (the patient still cannot walk).
I started have a persistent cough on Friday rights after the vaccine. (It was just that one day.) The next day, I was itching all over. On Monday, I noticed I had a rash. Tuesday, I went to the doctor and he said it was hives - he gave a Steroid shot, medication to stop the itching and Benadryl.
Patient became pale, nauseated and dizzy. Patient hyperventilating. Unable to control breathing. Bilateral hand and shoulder contractures noted. Patient placed in Trendelenburg. Color returned to normal and dizziness and nausea resolved. Contractures on left hand and shoulder resolved. Patient given juice and encouraged to breathe normally. Right hand remained contracted. Patient states she is "double jointed" and sometimes wakes in the morning with hand contractures. Patient ambulatory.
arm sore, could barely move arm;aching from head to toe & had fever 103;told by hosp not rxn-chills, h/a, nausea, arm red & swollen & puffy;PMD dx rxn to vax & cellulitis;
#1 taste changed can't eat papers anymore that i used to love, papers onions bananas and a number of other foods taste like a decomposed metallic taste, I used to be able to tell most ingredient in food by taste. I can't anymore, #2 ringing in ears head fills full, pressure in skull
High fever up to 103, headache, chills, nausea, sore musceles, fatigue. Symptoms started on the morning after the vaccine. Fever spiked quickly to 103. Currently  48h after the booster vaccine,  fever hovering between 96 to 102, going up and down. Ibuprofein and  cold compress used, these most likely stopped fever from going above 103.
Foot pain in both feet: balls of feet and heels. Debilitating to the point that walking  must be limited to only in the home and only when absolutely necessary (for activities of daily living),  and even with continual, extensive rest there has been no improvement.  Custom orthotics actually aggravated the apparent inflammation. Podiatrists and foot and ankle surgeon whom I've consulted have expressed that it's unusual that my feet would be so painful when upon examination they appear to be normal.
she administered a Daptacel vaccine to a 15 month-old child before realizing that it was expired/ no AE; Initial information received on 11-Feb-2020 regarding an unsolicited valid non-serious case received from a certified nursing assistant (CNA).  This case involves a 15 months old male patient who was administered expired dose of DIPHTHERIA-15/TETANUS/5 AC PERTUSSIS VACCINE [DAPTACEL] vaccine (expired product administered).  Medical history, medical treatment, family history were not provided.  The patient had received DTaP vaccine in past.  Concomitant vaccinations included PNEUMOCOCCAL VACCINE CONJ 13V (CRM197) (PREVNAR 13) for Immunisation; and HIB VACCINE CONJ (TET TOX) (ACTHIB) for Immunisation.  On 11-Feb-2020, the patient received a 0.5mL dose of (frequency: once) suspect DIPHTHERIA-15/TETANUS/5 AC PERTUSSIS VACCINE lot C5366AA expiry date 07-Feb-2020 via intramuscular route in the left thigh for prophylactic vaccination.  This was a case of actual medication error due to expired product administered.  No adverse event reported.  This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in Directive and Module VI of the Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.
Headaches, Insomnia, Fasciculations(muscle twitches) Body Tremors, Atrophy, Limb Weakness,  Ear Ringing, Neck & Back pain , Numb Toes , Aching fingers
Fever, headache, fatigue after injection for 2 days.  1/25 becoming ill with cold, turned into severe sore throat, swollen tonsils, swollen lymph nodes.
Cellulitis of left arm (worsenign redness, swelling and pain with underlying induration; starting >24 hours post vaccine)
Significant itch, redness + swelling at vaccine site starting approximately 8 hours after administration associated with moderate headache persisting at recheck on 4/3/9.
This spontaneous report as received from a female consumer of unknown age refers to herself (weight 200, height 5 feet 7 in). The patient had shingles in the past. One year ago approximately in July 2012, the patient was vaccinated with ZOSTAVAX (lot number, dose, strength, frequency, route and site unspecified). The patient was now presenting shingles (date unspecified). The outcome of shingles was unknown. It was unspecified if the patient had sought medical attention. Additional information is not expected.
Pt started to feel very nauseous and got hives on her chest, back and shoulders within 2 hrs of receiving flu vaccine on 10/4/16. She took BENADRYL which helped her symptoms.
Complaining of pain for 5 days after shot was given. Now he has large lump where shot was given 6 days later and still complains of pain.
Per granddaughter's report, pt became very weak within hours of receiving the first dose of the Moderna COVID-19 vaccine and could not get out of bed the next morning without assistance, reported difficulty seeing, and did not recognize some family members. By Sunday, 1/31, pt was unable to be awakened, would not eat, and had low urinary output. Granddaughter reports that the morning of 2/1 he was awake and ate a small amount and seemed to be improving although still weak and unable to get out of bed.  Granddaughter reported he died 2/1 around 10am in the morning.
Site of injection was sore and 3 days after shot redness around the injection site spread to around 15cm diameter.  the reddness has deminised over the last 3 days and is now just itchy around the edges where the redness was/is.
This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient. A 53-year-old male patient received BNT162b2, BNT162b2 omi ba.4-5 (BNT162B2, BNT162B2 OMI BA.4-5), on 25Oct2022 at 13:00 as dose 4 (booster), single (Lot number: GH9702) at the age of 53 years, in left arm for covid-19 immunisation; coviD-19 vaccine (COVID-19 VACCINE), as dose 1, single (Batch/Lot number: unknown), as dose 2, single (Batch/Lot number: unknown) and as dose 3 (booster), single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history included: "Celiac disease" (unspecified if ongoing); "bladder cancer" (unspecified if ongoing). There were no concomitant medications. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant) all with onset 2022, outcome "unknown" and all described as "COVID 19 Treatment". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: (2022) Positive, notes: COVID 19 Treatment. Therapeutic measures were taken as a result of drug ineffective, covid-19. Additional information: Known Allergies were reported as No.
18 patients received a dose given greater than 12 hours after puncture; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (18 patients received a dose given greater than 12 hours after puncture) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030B21A) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced EXPIRED PRODUCT ADMINISTERED (18 patients received a dose given greater than 12 hours after puncture). At the time of the report, EXPIRED PRODUCT ADMINISTERED (18 patients received a dose given greater than 12 hours after puncture) had resolved.            Concomitant product was not provided by the reporter. Treatment information was not provided.   Most recent FOLLOW-UP information incorporated above includes: On 23-Aug-2021: TCR document received on 25-Aug-2021 included reporter's fax number.; Action taken for Product Details updated to Not Applicable , Medication Error Case.
numb lips 10 min post-vaccination.  no respiratory distress.  no uriticaria.  Stable vitals. Given diphenhydramine 12.5mg x 1.  Discharged from vaccination site.
herpes zoster; This initial spontaneous report was received from a lawyer regarding a case in litigation and refers to a male patient.  No information was received regarding medical history, concurrent conditions, or concomitant medications.  In 2013 (patient was approximately 86 years old at this time), the patient was prescribed zoster vaccine live (ZOSTAVAX) by a healthcare provider for the long-term prevention of shingles and zoster-related conditions.  In 2013, the patient was administered zoster vaccine live (ZOSTAVAX) by a healthcare provider at a hospital (dose, route, and lot # not provided).  On an unspecified date, the patient was treated by a healthcare provider at the same hospital for the following injuries resulting from the patient's zoster vaccine live (ZOSTAVAX) use: herpes zoster.  The outcome of herpes zoster was unknown.  Causality assessment was related.  Additional information has been requested.
headache; nervous feeling; extreme diarrhea; arm itching; blood pressure has been higher than usual; arm swollen/red; arm swollen/red; fatigue; clammy eyes; This spontaneous case was reported by a consumer and describes the occurrence of HEADACHE (headache), NERVOUSNESS (nervous feeling), DIARRHOEA (extreme diarrhea), ABNORMAL SENSATION IN EYE (clammy eyes) and PRURITUS (arm itching) in a 77-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 019B21A and 029A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included No adverse event (No medical history reported).   On 12-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 09-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 09-Mar-2021, the patient experienced ABNORMAL SENSATION IN EYE (clammy eyes). On 09-Apr-2021, the patient experienced HEADACHE (headache), NERVOUSNESS (nervous feeling), DIARRHOEA (extreme diarrhea), PRURITUS (arm itching), HYPERTENSION (blood pressure has been higher than usual), PERIPHERAL SWELLING (arm swollen/red), ERYTHEMA (arm swollen/red) and FATIGUE (fatigue). The patient was treated with PARACETAMOL (TYLENOL) at a dose of 1 dosage form and ISOPROPANOL (RUBBING ALCOHOL) at a dose of 1 dosage form. On 11-Apr-2021, DIARRHOEA (extreme diarrhea) had resolved. At the time of the report, HEADACHE (headache), NERVOUSNESS (nervous feeling), ABNORMAL SENSATION IN EYE (clammy eyes), PRURITUS (arm itching), HYPERTENSION (blood pressure has been higher than usual), PERIPHERAL SWELLING (arm swollen/red), ERYTHEMA (arm swollen/red) and FATIGUE (fatigue) outcome was unknown.            No concomitant medications were reported.   This case was linked to US-MODERNATX, INC.-MOD-2021-075011 (E2B Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2021-075011:CROSSLINKED WITH DOSE 1
afebrile morbilloform exanthem, cephalocaudal onset 7 days post vaccination no treatment
Dizziness, Headache, Sore Throat, Night Sweats, Fatigue.
Information has been received from a Doctor of science who authored an article published in journal. The author reported that a breast-feeding mother on unspecified date was vaccinated with GARDASIL and that shortly following the vaccination her baby died. The author stated that both mother and child were completely healthy prior to the vaccination. The mother's experience has been captured in WAES 1107USA04018. No further information is available.
Onset of general pain - especially at injection site and back, redness, erythema at injection site, then progressed to other parts of body. Required administration of injectable Beandryl
Muscle tightness at injection site; Warm injection site; Redness injection site; Itchy injection site; Swollen injection site; mild pain at the injection site; This spontaneous case was reported by a consumer and describes the occurrence of MUSCLE TIGHTNESS (Muscle tightness at injection site), VACCINATION SITE WARMTH (Warm injection site), VACCINATION SITE PAIN (mild pain at the injection site), VACCINATION SITE ERYTHEMA (Redness injection site) and VACCINATION SITE PRURITUS (Itchy injection site) in a 78-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 22-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 22-Jan-2021, the patient experienced VACCINATION SITE PAIN (mild pain at the injection site). On 30-Jan-2021, the patient experienced MUSCLE TIGHTNESS (Muscle tightness at injection site), VACCINATION SITE WARMTH (Warm injection site), VACCINATION SITE ERYTHEMA (Redness injection site), VACCINATION SITE PRURITUS (Itchy injection site) and VACCINATION SITE SWELLING (Swollen injection site). At the time of the report, MUSCLE TIGHTNESS (Muscle tightness at injection site), VACCINATION SITE WARMTH (Warm injection site), VACCINATION SITE PAIN (mild pain at the injection site), VACCINATION SITE ERYTHEMA (Redness injection site), VACCINATION SITE PRURITUS (Itchy injection site) and VACCINATION SITE SWELLING (Swollen injection site) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment and concomitant medications were not provided by reporter.
Day of second vaccine: weakness, fever, night sweats,  flu symptoms, arm pain for one week  Extreme fatigue weakness ,tiredness, and fatigue have not diminished and unable to do everyday task since second vaccine
NIGHT TIME DELIRIUM, NOT REMEMBERING FALLING AND BRUISING ARM AND FOREHEAD ON NIGHTSTAND(?), WAKING UP ON FLOOR, ON 2ND NIGHT POST VACCINE, WAKING UP WITH NAIL WOUNDS ON SKIN, WALKING IN SLEEP, ECT. NO PREVIOUS OCCURENCE  OF ANY OF THE ABOVE. EXTREME FEELING OF BEING DRUGGED. NO ALCOHOL, NO MEDICATIONS.
Patient received 1st dose Moderna on 2-17-2021 and 10 days later patient relapsed on ALL (type of Leukemia). Per caregiver, patient has been in the hospital for 26 days. May or may not be related to vaccine. Patient will not be getting the 2nd dose.
Sore throat, inner ear pain, congestion and cough- no fever. Covid 19 diagnosis after positive antigen test; telemedicine visit and Paxlovid prescribed. Symptoms abated after 10 days.
Initial report received from a healthcare professional who is the patient on 01 November 2012. A 72-year-old female patient, with a history of back pain from herniated disc and illness at the time of vaccination was reported as none, had received a dose of FLUZONE HD vaccine in left deltoid (Lot number, dose number and route of vaccination were not reported) on 26 October 2012. On 26 October 2012, after receiving the vaccine, the patient presented swelling, redness, pain and tender to touch area around the injection site. The patient also experienced muscle aches in the left arm, headache, and irritability. As of 01 November 2012, some of the symptoms have subsided such as redness and swelling but other events were not recovered. Laboratory details were none and corrective treatment was not reported. The patient's outcome was not recovered. Documents held by sender: none.
Pain & allergic rash & Dr treated w/MEDROL dose pak & hydrocodone/APAP 5/500.
c/o bodyache, fever, sweathing, H pounding, and difficulty breathing since J&J shot @1130 today. took Tylenol x2 but not helped. last Tylenol @1830.
Patient received Johnson & Johnson 0.5ml  Covid vaccine IM to left deltoid. While in observation area, patient reported nausea and "tingling throat." BP 170/120, HR 98. Patient began vomiting, observed to be scratching arms. She reported feeling itchy everywhere. 911 called. Patient reported tongue "felt funny" and throat felt tight. Epinephrine 0.3mg administered IM to left thigh at 10:50am.  Patient reported almost immediate relief in symptoms after receiving Epinephrine. She was transported to local ED via EMS.
This spontaneous report was received from a Licensed Practical Nurse referring to an unspecified number of patients of unknown age and gender. There was no information about the patients' concurrent conditions, concomitant therapies or medical histories provided. On unknown dates, the patients were vaccinated with improperly stored doses of PROQUAD lot # M041082 with expiration date of 04-APR-2018 and lot # M042500 with expiration date of 17-APR-2018 (dose and route of administration were not reported) for prophylaxis. It was also reported that the sterile diluent lot # M014698 with expiration date of 21-NOV-2018 was improperly stored too. There was no adverse effect reported. Administered doses of vaccines and sterile diluent experienced temperature of excursion of 15 degrees Fahrenheit to 46 degrees Fahrenheit (22 degrees Fahrenheit) for 19 hours 30 minutes. Data logger was involved. There were no previous excursions reported. Additional information has been requested.
As of 01/09/2019 at 05:31pm there have not been any adverse events.
I can smell the smoking smell like someone is smoking next to me and it come and goes but more often I smell it the entire day.
Swelling and redness to outer portion of left arm, coughing, congestion. Injection site painful and warm to touch. Temperature  noticed this morning, did not take temp.
Patient's face flushed, mouth got dry, and was feeling hot.  She stated this reaction happens often because of her disorder, but in this case it lasted for an hour and she began to feel light headed and her heart rate was increased.  She was given water and a cold compress, before ultimately was brought to an urgent care center by her family members who were present at the facility.
Student had gotten a flu vaccine on 9/19/20. He came to the flu clinic on 1/26/21 and received another flu vaccine, his first dose being unbeknownst to the flu clinic staff.
Information has been received from a medical assistant referring to an unspecified number of patients of unknown age and gender. The patients' medical history and concurrent conditions were not reported. Concomitant therapies included sterile diluent (manufacturer unknown). On 01-SEP-2017, the patients were vaccinated with improperly stored PROQUAD (dose, frequency and route were unknown, lot # M044720, expiration date: 07-MAY-2018, lot # N013863, expiration date: 31-OCT-2018) for prophylaxis. Administered vaccine experienced the temperature excursion of -14 Celsius degree to -10 Celsius degree (-14.2 Celsius degree) for 6 hours. There was no previous temperature excursion. Data logger was involved. No adverse effects reported. No product quality complaint (PQC) was involved. All telephone attempts on 10-OCT-2017 to obtain follow up information have been unsuccessful. Follow up information has been received from another reporter concerning a 4 year old patient. On 15-SEP-2017, the patient vaccinated with improperly stored PROQUAD (dose, frequency and route were unknown, lot # N016089, expiration date: 22-NOV-2019) for prophylaxis. This is one of several reports from the same reporter. Sender's Comments: US-009507513-1709USA002186: US-009507513-1709USA002098.
This spontaneous report as received from a Registered Nurse refers to a patient of unknown age with no pertinent medical history/drug allergies or drug reactions reported. On 29-MAY-2015, the patient was vaccinated with a dose of improperly stored (Oka-Merck) PROQUAD (route, dose and anatomical location were not reported), lot # K022448 expiration date 13-MAY-2016. There was no concomitant therapy reported. No adverse effects reported. This is one of several reports received from the same reporter. Additional information has been requested.
Patient received the flu shot on 09/12/2019, and 5 hours later after getting the shot the patient experienced violent tremors over the whole body. She also experienced significant nausea without vomiting and dry heaving. Patient almost called the ambulance  but instead took 1mg of ativan. Her symptoms seemed to resolve. On the next day she was fine during the day but at night she developed a high fever.
Sore shoulder on side of vaccination (left), and sore hip on same side. Very painful to lift arm, and joints cracked when lifting arm. still undergoing PT. Soreness and cracking gradually going away  with massage, stretching, and strengthening exercises.